Solid forms of Cerdulatinib
US11713309B2 · kind B2 · utility
0Cited by
14References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2020 |
| Grant date | Aug 1, 2023 |
| Priority date | — |
| Expiry date | Nov 16, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.